Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

Penn scientists discover a cellular pathway that keeps Ebola virus from exiting human cells

MIT study helps shed light on why the immune system mounts a dull response to lung cancer

Boost Amazon Product Listing With The Best Amazon Photography

Study: Latinx students experienced higher rates of depression and anxiety during the pandemic

Groundbreaking technique offers a new way to gain detailed information about organic tissues

LGB preteens report 10.4 hours of daily recreational screen time

Comments

Leave a reply Cancel reply

More in News

New statistical model could help doctors improve outcomes for pediatric tonsillectomies

Study identifies high levels of burnout across all members of the healthcare workforce

New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

Study shows a genetic association of diarrhea in children

Important

Saving For Retirement, Don’t Forget To Claim Saver’s Credit

Swedish men and women with higher incomes have more children, study shows

One minute of blue, green or red-light exposure modifies the functional connectivity of neural networks

Must Read

Genomic analysis of mpox virus genomes reveal multiple lineages with human-to-human transmissibility

‘Yellowjackets’ Season 2, episode 2 trailer teases buzzy new mysteries

Does irritable bowel syndrome result from gravity?

Popular Posts

Pornhub traffic doubled in D.C. on Election Day

12 sex tips for disabled people and their partners

User Experience Signals: The Essential SEO Factors

Lunar eclipse November 8: How to watch the last ‘blood moon’ of 2022